The biology of estrogen-mediated repair of cardiovascular injury

Annals of Thoracic Surgery

Volumn 65, Issue 3, 1998, Pages 868-874

  Selzman, Craig H ^a   Whitehill, Thomas A ^a   Shames, Brian D ^a   Pulido, Edward J ^a   Cain, Brian C ^a   Harken, Alden H ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ESTROGEN; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; L SELECTIN; NITRIC OXIDE; PADGEM PROTEIN; PROSTAGLANDIN; VASCULAR CELL ADHESION MOLECULE 1; VERY LATE ACTIVATION ANTIGEN 1;

ATHEROGENESIS; CARDIOVASCULAR DISEASE; ESTROGEN METABOLISM; ESTROGEN THERAPY; HEART PROTECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKOCYTE ADHERENCE; LIPID METABOLISM; PRIORITY JOURNAL; REVIEW;

CARDIAC SURGICAL PROCEDURES; CELL ADHESION; CORONARY ARTERIOSCLEROSIS; CYTOKINES; ENDOTHELIUM, VASCULAR; ESTROGENS; EXTRACELLULAR MATRIX; GROWTH SUBSTANCES; HUMANS; LEUKOCYTES; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; PROSTAGLANDINS;

EID: 0032033057     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(97)01377-5     Document Type: Review

References (56)

1. Ross R. The pathogenesis of atherosclerosis a perspective for the 1990s . Nature. 362:1993;801-809.
2. Grodstein F, Stampfer MJ, Colditz GA, et al. Postmenopausal hormone therapy and mortality. N Engl J Med. 336:1997;1769-1775.
3. Bush TL, Barrett-Connor E, Cowan LD, et al. Cardiovascular mortality and noncontraceptive use of estrogen in women results from the Lipid Research Clinics Program Follow-up Study . Circulation. 75:1987;1102-1109.
4. Ambrus JL, Schimert G, Lajos TZ, et al. Effect of antifibrinolytic agents and estrogens on blood loss and blood coagulation factors during open heart surgery. J Med. 2:1971;65-81.
5. Hull RW, Hasbargen JA, Fall S, O'Barr TP. Conjugated estrogens reduce endothelial prostacyclin production and fail to reduce postbypass blood loss. Chest. 99:1991;1116-1119.
6. Pick R, Stamler J, Rodbard S, Katz LN. The inhibition of coronary atheromatosis in cholesterol-fed chicks receiving estrogens. Circulation. 4:1951;468.
7. Kushwaha RS, Lewis DS, Carey KD, McGill HC. Effects of estrogen and progesterone on plasma lipoproteins and experimental atherosclerosis in the baboon. Arterioscler Thromb. 11:1991;23-31.
8. Adams MR, Kaplan JR, Manuck SB, et al. Inhibition of coronary artery atherosclerosis by 17β-estradiol in ovariectomized monkeys - lack of an effect of added progesterone. Arteriosclerosis. 10:1990;1051-1057.
9. Foegh ML, Khirabadi BS, Nakanishi T, Vargas R, Ramwell PW. Estradiol protects against experimental cardiac transplant atherosclerosis. Transplant Proc. 19:1987;90-95.
10. Cheng LP, Kuwahara M, Jacobsson J, Foegh ML. Inhibition of myointimal hyperplasia and macrophage infiltration by estradiol in aorta allografts. Transplantation. 52:1991;967-972.
11. Lou H, Kodama T, Zhao J, et al. Inhibition of transplant coronary arteriosclerosis in rabbits by chronic estradiol treatment is associated with abolition of MHC class II antigen expression. Circulation. 94:1996;3355-3361.
12. Rhee CY, Spaet TH, Stemerman MB, et al. Estrogen suppression of surgically induced vascular intimal hyperplasia in rabbits. J Lab Clin Med. 90:1977;77-84.
13. Sullivan TR, Karas RH, Aronovitz M, et al. Estrogen inhibits the response-to-injury in a mouse carotid artery model. J Clin Invest. 96:1995;2482-2488.
14. O'Keefe JH, Kim SC, Hall RR, et al. Estrogen replacement therapy after coronary angioplasty in women. J Am Coll Cardiol. 29:1997;1-5.
15. Sullivan JM, El-Zeky F, Vander Zwaag R, Ramanathan KB. Effect on survival of estrogen replacement therapy after coronary artery bypass grafting. Am J Cardiol. 79:1997;847-850.
16. Krasinski KL, Silver M, Asahara T, Losordo DW. Estrogen replacement therapy accelerates re-endothelialization of balloon injured arteries in ovariectomized rat model [Abstract]. Circulation. 94:(Suppl 1):1996;150.
17. Gagliardi AR, Hennig B, Collins DC. Antiestrogens inhibit endothelial cell growth stimulated by angiogenic growth factors. Anticancer Res. 16:1996;1101-1106.
18. Spyridopoulos I, Sullivan A, Kearney M, Isner JM, Losordo DW. Estrogen-receptor mediated inhibition of human endothelial cell apoptosis - estradiol as a survival factor. Circulation. 85:1997;1505-1514.
19. 1α by uterine arteries from postmenopausal women. Am J Obstet Gynecol. 161:1989;1677-1681.
20. Fogelberg M, Vesterqvist O, Diczfalusy U, Henriksson P. Experimental atherosclerosis effects of oestrogen and atherosclerosis on thromboxane and prostacyclin formation . Eur J Clin Invest. 20:1990;105-110.
21. Mikkola T, Turunen P, Avela K, et al. 17β-Estradiol stimulates prostacyclin, but not endothelin-1, production in human vascular endothelial cells. J Clin Endocrinol Metab. 80:1995;1832-1836.
22. Redmond EM, Cherian MN, Wetzel RC. 17β-Estradiol inhibits flow- and acute hypoxia-induced prostacyclin release from perfused endocardial endothelial cells. Circulation. 90:1994;2519-2524.
23. Rosano GMC, Sarrel PM, Poole-Wilson PA, Collins P. Beneficial effect of oestrogen on exercise-induced myocardial ischaemia in women with coronary artery disease. Lancet. 342:1993;133-136.
24. Herrington DM, Braden GA, Williams HK, Morgan TM. Endothelial-dependent coronary vasomotor responsiveness in postmenopausal women with and without estrogen replacement therapy. Am J Cardiol. 73:1994;951-952.
25. Gilligan DM, Quyyumi AA, Cannon RO. Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. Circulation. 89:1994;2545-2551.
26. Farhat MY, Lavigne MC, Ramwell PW. The vascular protective effects of estrogens. FASEB J. 10:1996;615-624.
27. Lieberman EH, Gerhard MD, Uehata A, et al. Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women. Ann Intern Med. 121:1994;936-941.
28. Hishikawa K, Nakaki T, Marumo T, et al. Up-regulation of nitric oxide synthase by estradiol in human aortic endothelial cells. FEBS Lett. 360:1995;291-293.
29. Jilma B, Eichler HG, Breiteneder H, et al. Effects of 17β-estradiol on circulating adhesion molecules. J Clin Endocrinol Metab. 79:1994;1619-1624.
30. Nathan L, Pervin S, Singh R, et al. Estradiol reduces monocyte adherence to vascular endothelium in vivo [Abstract]. Circulation. 94:(Suppl 1):1996;151.
31. Cid MC, Kleinman HK, Grant DS, et al. Estradiol enhances leukocyte binding to tumor necrosis factor-stimulated endothelial cells via an increase in TNF-induced adhesion molecules E-selectin, intercellular adhesion molecule type 1, and vascular cell adhesion molecule type 1. J Clin Invest. 93:1994;17-25.
32. Aziz KE, Wakefield D. Modulation of endothelial cell expression of ICAM-1, E-selectin, and VCAM-1 by β-estradiol, progesterone, and dexamethasone. Cell Immunol. 167:1996;79-85.
33. Nakai K, Itoh C, Hotta K, et al. Estradiol-17β regulates the induction of VCAM-1 mRNA expression by interleukin-1β in human umbilical vein endothelial cells. Life Sci. 54:1994;221-227.
34. Caulin-Glaser T, Watson CA, Pardi R, Bender JR. Effects of 17β-estradiol on cytokine-induced endothelial cell adhesion molecule expression. J Clin Invest. 98:1996;36-42.
35. Weusten JAM, Blankenstein MA, Gmelig-Meyling FHJ, et al. Presence of oestrogen receptors in human blood mononuclear cells and thymocytes. Acta Endocrinol. 112:1986;409-414.
36. Cannon JG, Dinarello CA. Increased plasma interleukin-1 activity in women after ovulation. Science. 227:1985;1247-1249.
37. Polan ML, Kaniele A, Kuo A. Gonadal steroids modulate human monocyte interleukin-1 activity. Fertil Steril. 49:1988;964-968.
38. Kassem M, Khosla S, Spelsberg TC, Riggs BL. Cytokine production in the bone marrow microenvironment failure to demonstrate estrogen regulation in early postmenopausal women . J Clin Endocrinol Metab. 81:1996;513-518.
39. Stock JL, Coderre JA, McDonald B, Rosenwasser LJ. Effects of estrogen in vivo and in vitro on spontanteous interleukin-1 release by monocytes from postmenopausal women. J Clin Endocrinol Metab. 68:1989;364-368.
40. Pacifici R, Brown C, Puscheck E, et al. Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells. Proc Natl Acad Sci USA. 88:1991;5134-5138.
41. Polan ML, Loukides J, Nelson P, et al. Progesterone and estradiol modulate interleukin-1β messenger ribonucleic acid levels in cultured human peripheral monocytes. J Clin Endocrinol Metab. 69:1989;1200-1207.
42. Zuckerman SH, Bryan-Poole N, Evans GF, Short L, Glasebrook AL. In vivo modulation of murine serum tumour necrosis factor and interleukin-6 levels during endotoxemia by oestrogen agonists and antagonists. Immunology. 86:1995;18-24.
43. Aune B, Oian P, Omsjo I, Osterud B. Hormone replacement therapy reduces the reactivity of monocytes and platelets in whole blood - a beneficial effect on atherogenesis and thrombus formation. Am J Obstet Gynecol. 173:1995;1816-1820.
44. Ralston SH, Russell RG, Gowen M. Estrogen inhibits release of tumor necrosis factor from peripheral blood mononuclear cells in postmenopausal women. J Bone Miner Res. 5:1990;983-988.
45. Loy RA, Loukides JA, Polan ML. Ovarian steroids modulate human monocyte tumor necrosis factor alpha messenger ribonucleic acid levels in cultured human peripheral monocytes. Fertil Steril. 58:1992;733-739.
46. Van der Burg B, De Groot RP, Isbrucker L, Kruijer W, De Laat SW. Direct stimulation by estrogen of growth factor signal transduction pathways in human breast cancer cells. J Steroid Biochem Molec Biol. 43:1992;111-115.
47. Newton CJ, Buric R, Trapp R, et al. The unliganded estrogen receptor (ER) transduces growth factor signals. J Steroid Biochem Molec Biol. 48:1994;481-486.
48. Friend KE, Hartman ML, Pezzoli SS, Clasey JL, Thorner MO. Both oral and transdermal estrogen increase growth hormone release in postmenopausal women - a clinical research center study. J Clin Endocrinol Metab. 81:1996;2250-2256.
49. Drummond AE, McPherson SJ, Laslett A, Hearn MT. Application of a chromogenic bioassay procedure for the measurement of the proliferation of endothelial cells in vitro under the influence of the effects of steroid hormones and growth factors. J Biochem Biophys Meth. 31:1996;123-134.
50. Lou H, Ramwell P, Foegh M. Estradiol down-regulates insulin-like growth factor-I receptor (IGF-Ir) mRNA expression in aortic smooth muscle cells [Abstract]. Circulation. 94:(Suppl 1):1996;152.
51. Losordo DW, Kearney M, Kim EA, Jekanowski J, Isner JM. Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women. Circulation. 89:1994;1501-1510.
52. Saladino CF, Yeh Q, Zimmer E, Jonas EA. The effect of atherogenic infusions of the triglyceride-rich lipid emulsion, lipofundin-s, on the in vitro growth characteristics of rat aortic smooth muscle cells. Artery. 19:1992;76-93.
53. Suzuki A, Mizuno K, Ino Y, et al. Effects of 17β-estradiol and progesterone on growth-factor induced proliferation and migration in human female aortic smooth muscle cells in vitro. Cardiovasc Res. 32:1996;516-523.
54. Kolodgie FD, Jacob A, Wilson PS, et al. Estradiol attenuates directed migration of vascular smooth muscle cells in vitro. Am J Pathol. 148:1996;969-976.
55. Fischer GM, Swain ML. Effects of estradiol and progesterone on the increased synthesis of collagen in atherosclerotic rabbit aortas. Atherosclerosis. 54:1985;177-185.
56. Beldekas JC, Smith B, Gerstenfeld LC, Sonenshein GE, Franzblau C. Effects of 17β-estradiol on the biosynthesis of collagen in cultured bovine aortic smooth muscle cells. Biochemistry. 20:1981;2162-2167.